Evofem Bioscience Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -46,151 | -142,309 | -101,711 | -71,812 | -19,146 |
| Depreciation Amortization | 195 | 302 | 181 | 123 | 69 |
| Accounts receivable | -1,847 | -1,067 | -1,243 | 0 | N/A |
| Accounts payable and accrued liabilities | -4,647 | 4,126 | -505 | 1,697 | 996 |
| Other Working Capital | 6,410 | -15,227 | -9,904 | 1,644 | 636 |
| Other Operating Activity | 11,582 | 49,346 | 47,432 | 38,420 | 2,569 |
| Operating Cash Flow | $-34,458 | $-104,829 | $-65,750 | $-29,928 | $-14,876 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 8,233 | 8,233 | 8,233 | 6,747 |
| PPE Investments | -956 | -2,254 | -833 | -536 | -95 |
| Net Acquisitions | 250 | 250 | 250 | 250 | 250 |
| Investing Cash Flow | $-706 | $6,229 | $7,650 | $7,947 | $6,902 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 50,000 | 25,000 | 25,000 | N/A |
| Common Stock Issued | 28,050 | 107,968 | 107,858 | 107,858 | 1,584 |
| Other Financing Activity | -44 | -3,742 | -3,549 | -2,946 | -220 |
| Financing Cash Flow | $28,006 | $154,226 | $129,309 | $129,912 | $1,364 |
| Beginning Cash Position | 72,251 | 16,625 | 16,625 | 16,625 | 16,625 |
| End Cash Position | 65,093 | 72,251 | 87,834 | 124,556 | 10,015 |
| Net Cash Flow | $-7,158 | $55,626 | $71,209 | $107,931 | $-6,610 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,458 | -104,829 | -65,750 | -29,928 | -14,876 |
| Capital Expenditure | -956 | -2,254 | -833 | -536 | -95 |
| Free Cash Flow | -35,414 | -107,083 | -66,583 | -30,464 | -14,971 |